TLRY Tilray Brands
Updated
Healthcare · Medicinal Chemicals & Botanical Products
Tilray Brands (TLRY) is a healthcare company in the Medicinal Chemicals & Botanical Products industry, with a market capitalization of $616 million. Shares last traded at $4.52, 71.2% below their 52-week high. Net profit margin is -13.3%, below the peer median of -8.5%. Revenue grew 11.5% year over year.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-05-31 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| FY 2026 | $-1.09 | 2026-07-28 |
| Q3 2026 | $-0.65 | 2026-04-01 |
| Q2 2026 | $-0.42 | 2026-01-08 |
| Q1 2026 | $0.00 | 2025-10-09 |
| FY 2026 | $-24.56 | 2026-07-28 |
| Q3 2026 | $-10.62 | 2026-04-01 |
Medicinal Chemicals & Botanical Products peers
TLRY vs 14 industry peers (Medicinal Chemicals & Botanical Products), by market cap. Updated
| DFTX | Definium Therapeutics, Inc. | $5.1B | -14.43 | — | — | -2.40% |
| TRLV | Trulieve Cannabis Corp. | $2.3B | -4.86 | 2.03 | -41.8% | +2.56% |
| TLRY | Tilray Brands | $616M | -5.07 | 0.67 | -13.3% | +0.11% |
| USNA | USANA HEALTH SCIENCES INC | $267M | -12.03 | 0.29 | -2.4% | -1.30% |
| NAGE | Niagen Bioscience, Inc. | $246M | 15.41 | 1.91 | 12.4% | -1.89% |
| FTLF | FITLIFE BRANDS, INC. | $93M | 14.86 | 0.91 | 6.2% | -3.10% |
| BTMD | biote Corp. | $46M | 7.82 | 0.25 | 3.2% | -9.91% |
| MTEX | MANNATECH INC | $14M | -1.90 | 0.13 | -6.9% | -2.93% |
| NAII | NATURAL ALTERNATIVES INTERNATIONAL INC | $12M | -0.86 | 0.09 | -10.1% | -0.47% |
| SNYR | Synergy CHC Corp. | $2M | -0.10 | 0.06 | -57.0% | -2.03% |
| CRON | Cronos Group | — | — | — | 39.1% | +0.46% |
| CGC | Canopy Growth | — | — | — | -80.4% | +0.27% |
| GLAS | Glass House Brands Inc. | — | — | — | -16.3% | +3.61% |
| IMCC | IM Cannabis Corp. | — | — | — | — | -27.57% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.